Effect of DHA Supplementation During Pregnancy on Maternal Depression and Neurodevelopment of Young Children: A Randomized Controlled Trial | Child Development | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Golding J, Steer C, Emmett P, Davis JM, Hibbeln  JR. High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish.  Epidemiology. 2009;20(4):598-60319289957PubMedGoogle ScholarCrossref
Hibbeln JR, Davis JM, Steer C,  et al.  Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study.  Lancet. 2007;369(9561):578-58517307104PubMedGoogle ScholarCrossref
Oken E, Radesky JS, Wright RO,  et al.  Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort.  Am J Epidemiol. 2008;167(10):1171-118118353804PubMedGoogle ScholarCrossref
Brenna JT, Lapillonne A. Background paper on fat and fatty acid requirements during pregnancy and lactation.  Ann Nutr Metab. 2009;55(1-3):97-12219752538PubMedGoogle ScholarCrossref
Ramakrishnan U, Imhoff-Kunsch B, DiGirolamo AM. Role of docosahexaenoic acid in maternal and child mental health.  Am J Clin Nutr. 2009;89(3):958S-962S19176728PubMedGoogle ScholarCrossref
Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age.  Pediatrics. 2003;111(1):e39-e4412509593PubMedGoogle ScholarCrossref
Dunstan JA, Simmer K, Dixon G, Prescott SL. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial.  Arch Dis Child Fetal Neonatal Ed. 2008;93(1):F45-F5017185423PubMedGoogle ScholarCrossref
Judge MP, Harel O, Lammi-Keefe CJ. A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age.  Lipids. 2007;42(2):117-12217393217PubMedGoogle ScholarCrossref
Malcolm CA, McCulloch DL, Montgomery C, Shepherd A, Weaver LT. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial.  Arch Dis Child Fetal Neonatal Ed. 2003;88(5):F383-F39012937042PubMedGoogle ScholarCrossref
Koletzko B, Cetin I, Brenna JT.Perinatal Lipid Intake Working Group; Child Health Foundation; Diabetic Pregnancy Study Group; European Association of Perinatal Medicine; European Association of Perinatal Medicine; European Society for Clinical Nutrition and Metabolism; European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Committee on Nutrition; International Federation of Placenta Associations; International Society for the Study of Fatty Acids and Lipids.  Dietary fat intakes for pregnant and lactating women.  Br J Nutr. 2007;98(5):873-87717688705PubMedGoogle ScholarCrossref
Pascoe JM, Ialongo NS, Horn WF, Reinhart MA, Perradatto D. The reliability and validity of the maternal social support index.  Fam Med. 1988;20(4):271-2763203834PubMedGoogle Scholar
Hibbeln JR, Davis JM. Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids.  Prostaglandins Leukot Essent Fatty Acids. 2009;81(2-3):179-18619619995PubMedGoogle ScholarCrossref
Meyer BJ, Mann NJ, Lewis JL, Milligan GC, Sinclair AJ, Howe PR. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids.  Lipids. 2003;38(4):391-39812848284PubMedGoogle ScholarCrossref
Smithers LG, Gibson RA, McPhee A, Makrides M. Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial.  Prostaglandins Leukot Essent Fatty Acids. 2008;79(3-5):141-14618951004PubMedGoogle ScholarCrossref
Boyce P, Stubbs J, Todd A. The Edinburgh Postnatal Depression Scale: validation for an Australian sample.  Aust N Z J Psychiatry. 1993;27(3):472-4768250792PubMedGoogle ScholarCrossref
Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale.  Br J Psychiatry. 1987;150(Jun):782-7863651732PubMedGoogle ScholarCrossref
Murray L, Carothers AD. The validation of the Edinburgh Post-natal Depression Scale on a community sample.  Br J Psychiatry. 1990;157(Aug):288-2902224383PubMedGoogle ScholarCrossref
Brown S, Lumley J. Maternal health after childbirth: results of an Australian population based survey.  Br J Obstet Gynaecol. 1998;105(2):156-1619501779PubMedGoogle ScholarCrossref
Makrides M, Gibson RA, McPhee AJ,  et al.  Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial.  JAMA. 2009;301(2):175-18219141765PubMedGoogle ScholarCrossref
Carpenter DO. Effects of metals on the nervous system of humans and animals.  Int J Occup Med Environ Health. 2001;14(3):209-21811764847PubMedGoogle Scholar
Walter T, De Andraca I, Chadud P, Perales CG. Iron deficiency anemia: adverse effects on infant psychomotor development.  Pediatrics. 1989;84(1):7-172472596PubMedGoogle Scholar
Anderson PJ, Doyle LW. Cognitive and educational deficits in children born extremely preterm.  Semin Perinatol. 2008;32(1):51-5818249240PubMedGoogle ScholarCrossref
Chan A, Scott J, Nguyen A-M, Sage L. Pregnancy Outcome in South Australia 2007. Adelaide: Pregnancy Outcome Unit, South Australian Department of Health; 2008
Chan A, Scott J, Nguyen A-M, Sage L. Pregnancy Outcome in South Australia 2006. Adelaide: Pregnancy Outcome Unit, South Australian Department of Health; 2007
Braunholtz DA, Edwards SJL, Lilford RJ. Are randomized clinical trials good for us (in the short term)? evidence for a “trial effect.”  J Clin Epidemiol. 2001;54(3):217-22411223318PubMedGoogle ScholarCrossref
Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS.Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group.  Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.  N Engl J Med. 2005;352(24):2477-248615951574PubMedGoogle ScholarCrossref
Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction.  Cochrane Database Syst Rev. 2006;3(issue 3):CD00340216856006PubMedGoogle Scholar
Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C.Fish Oil Trials In Pregnancy (FOTIP) Team.  Randomised clinical trials of fish oil supplementation in high risk pregnancies.  BJOG. 2000;107(3):382-39510740336PubMedGoogle ScholarCrossref
Al MD, van Houwelingen AC, Kester AD, Hasaart TH, de Jong AE, Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status.  Br J Nutr. 1995;74(1):55-687547829PubMedGoogle ScholarCrossref
Innis SM. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids.  J Pediatr. 2003;143(4):(suppl)  S1-S814597908PubMedGoogle Scholar
Original Contribution
October 20, 2010

Effect of DHA Supplementation During Pregnancy on Maternal Depression and Neurodevelopment of Young Children: A Randomized Controlled Trial

Author Affiliations

Author Affiliations: Child Nutrition Research Centre, Women's and Children's Hospital, Flinders Medical Centre, and Women's and Children's Health Research Institute, Adelaide (Drs Makrides and Gibson); Schools of Pediatrics and Reproductive Health (Dr Makrides), Agriculture, Food and Wine (Dr Gibson), and Population Health and Clinical Practice (Dr Ryan and Ms Yelland), University of Adelaide, Adelaide; Department of Neonatal Medicine, Women's and Children's Hospital, Adelaide (Dr McPhee); and School of Medicine, University of Notre Dame Australia, and Sunshine Hospital, Melbourne (Dr Quinlivan), Australia.

JAMA. 2010;304(15):1675-1683. doi:10.1001/jama.2010.1507

Context Uncertainty about the benefits of dietary docosahexaenoic acid (DHA) for pregnant women and their children exists, despite international recommendations that pregnant women increase their DHA intakes.

Objective To determine whether increasing DHA during the last half of pregnancy will result in fewer women with high levels of depressive symptoms and enhance the neurodevelopmental outcome of their children.

Design, Setting, and Participants A double-blind, multicenter, randomized controlled trial (DHA to Optimize Mother Infant Outcome [DOMInO] trial) in 5 Australian maternity hospitals of 2399 women who were less than 21 weeks' gestation with singleton pregnancies and who were recruited between October 31, 2005, and January 11, 2008. Follow-up of children (n = 726) was completed December 16, 2009.

Intervention Docosahexaenoic acid–rich fish oil capsules (providing 800 mg/d of DHA) or matched vegetable oil capsules without DHA from study entry to birth.

Main Outcome Measures High levels of depressive symptoms in mothers as indicated by a score of more than 12 on the Edinburgh Postnatal Depression Scale at 6 weeks or 6 months postpartum. Cognitive and language development in children as assessed by the Bayley Scales of Infant and Toddler Development, Third Edition, at 18 months.

Results Of 2399 women enrolled, 96.7% completed the trial. The percentage of women with high levels of depressive symptoms during the first 6 months postpartum did not differ between the DHA and control groups (9.67% vs 11.19%; adjusted relative risk, 0.85; 95% confidence interval [CI], 0.70-1.02; P = .09). Mean cognitive composite scores (adjusted mean difference, 0.01; 95% CI, −1.36 to 1.37; P = .99) and mean language composite scores (adjusted mean difference, −1.42; 95% CI, −3.07 to 0.22; P = .09) of children in the DHA group did not differ from children in the control group.

Conclusion The use of DHA-rich fish oil capsules compared with vegetable oil capsules during pregnancy did not result in lower levels of postpartum depression in mothers or improved cognitive and language development in their offspring during early childhood.

Trial Registration anzctr.org.au Identifier: ACTRN12605000569606